secwatch.observer — SEC 8-K summary
======================================

Issuer:     OMEGA HEALTHCARE INVESTORS INC (OHI)
CIK:        0000888491
Form:       8-K
Filed at:   2022-01-04T23:59:59+00:00
Accession:  0001104659-22-000711
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Omega Healthcare: Chief Corporate Development Officer Steve Insoft to depart Jan 1, 2022
--------------------------------------------------------------------------------

- Steven J. Insoft, Chief Corporate Development Officer, mutually agreed to terminate employment effective Jan 1, 2022.
- Employment agreements of other named executive officers amended to extend term to Dec 31, 2024.
- Annual salaries for those executives revised per Compensation Committee review.
- No replacement or interim officer named for Insoft's role.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/888491/000110465922000711/0001104659-22-000711-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/888491/000110465922000711/tm2135928d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-000711

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer